Human genetics testing firm 23andMe announced Tuesday it will voluntarily delist from the Nasdaq and deregister with the U.S.

Me on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange ...

On May 19, Regeneron Pharmaceuticals (NASDAQ: REGN) announced that it was the successful bidder for substantially all of 23andMe's assets, agreeing to pay $256 million for them. The deal is still ...

23andMe has said it wants to allow new bids by both parties with a deadline of 12th June, according to a Financial Times ...

(Reuters) -The founder of 23andMe, Anne Wojcicki, has asked a U.S. judge to reopen an auction for the genetic testing company, saying she has the support of a Fortune 500 company with a current market ...

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. ("23andMe" or the "Company") (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced its intention to file ...

Anne Wojcicki, co-founder of 23andMe, is urging a U.S. judge to reopen the genetic testing companys bankruptcy auction, ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.